Bladder Urothelial Cancer
November 2011
Antegrade Perfusion With Bacillus Calmette-Guérin in Patients With Non–Muscle-Invasive Urothelial Carcinoma of the Upper Urinary Tract: Who May Benefit?
Giannarini, G, Kessler, T, Birkhäuser, F.
2010- November
Comparison Between Laparoscopic and Open Radical Nephroureterectomy in a Contemporary Group of Patients: Are Recurrence and Disease-Specific Survival Associated with Surgical Technique?
Favaretto, RL, Shariat, SF.
Laparoscopic Nephroureterectomy: Is It Always as Good as Open Nephroureterectomy?
Zisman, A.
With the following reply to editorial
Reply from Authors re: Amnon Zisman. Laparoscopic Nephroureterectomy: Is It Always as Good as Open Nephroureterectomy? Eur Urol 2010;58:652–3
Favaretto, RL, Coleman, J.
2010 - October
The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center
Favaretto, RL, Shariat, SF.
Changes in Renal Function Following Nephroureterectomy May Affect the Use of Perioperative Chemotherapy
Kaag, MJ, O'Malley RL, O'Malley, P.
2010 - September
Second Resection for Non-Muscle-Invasive Bladder Carcinoma: Current Role and Future Perspectives
Babjuk M
2010 - August
Influence of Photoselective Vaporization of the Prostate on Sexual Function: Results of a Prospective Analysis of 149 Patients with Long-Term Follow-Up
Bruyere, F.
2010- June
Should Bladder Cuff Excision Remain the Standard of Care at Nephroureterectomy in Patients with Urothelial Carcinoma of the Renal Pelvis? A Population-based Study
Lughezzani G, Sun M, Perrotte P et al
Oncological outcomes following three different approaches to the distal ureter and bladder cuff in nephroureterectomy for primary upper urinary tract urothelial carcinoma
Li W-M, Shen J-T, Li C-C et al
with the following accompanying Editorial
Should Urologists always perform a bladder cuff resection during nephroureterectomy and which method should they use?
Zlotta A
2010 - May
Long-Term Efficacy Results of EORTC Genito-Urinary Group Randomized Phase 3 Study 30911 Comparing Intravesical Instillations of Epirubicin, Bacillus Calmette-Guérin, and Bacillus Calmette-Guérin plus Isoniazid in Patients with Intermediate- and High-Risk Stage Ta T1 Urothelial Carcinoma of the Bladder
Sylvester RJ, Brausi MA, Kirkels WJ et al
with the following accompanying Editorial and reply from the Authors
New Insights in Intravesical Treatment for Intermediate- and High-Risk Non–Muscle-Invasive Urothelial Bladder Carcinoma
Babjuk M
Reply from Authors re: Marko Babjuk. New Insights in Intravesical Treatment for Intermediate- and High-Risk Non–Muscle-Invasive Urothelial Bladder Carcinoma. Eur Urol 2010;57:774–6
Sylvester RJ, Brausi MA, Kirkali Z et al
2010 - April
Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract
Zigeuner R, Shariat SF, Margulis V et al
with the following accompanying Editorial and reply from the Authors
Prognostication of Upper Tract Urothelial Carcinoma: What Do We Really Need?
Dalbagni G
Reply from Authors re: Guido Dalbagni. Prognostication of Upper Tract Urothelial Carcinoma: What Do We Really Need? Eur Urol 2010;57:582–3
Zigeuner R, Langner C
2010 - March
The Application of Artificial Intelligence to Microarray Data: Identification of a Novel Gene Signature to Identify Bladder Cancer Progression
Catto JWF, Abbod MF, Wild PJ et al
with the following accompanying Editorial and reply from the Authors
Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward
DeGraff DJ
Reply from Authors re: David J. DeGraff. Novel Use of a Combined Artificial Intelligence Approach to Identify Patients with Noninvasive Urothelial Cell Carcinoma of the Urinary Bladder Who Are at Greatest Risk for Progression to Muscle-Invasive Disease: A Step Forward. Eur Urol 2010;57:407–8
Catto JWF, Hamdy FC
2010 - February
Prospective Randomized Controlled Trial of Robotic versus Open Radical Cystectomy for Bladder Cancer: Perioperative and Pathologic Results
Nix J, Smith A, Kurpad R et al
with the following accompanying Editorial and reply from the Authors
Moving towards evidence-based surgery
Hakenberg OW
Reply from Authors re: Oliver W. Hakenberg. Moving Towards Evidence-based Surgery. Eur Urol 2010;57:202–3
Nix J, Pruthi RS
A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder
Roth B, Wissmeyer MP, Zehnder P et al
with the following accompanying Editorial
Extent of Pelvic Lymph Node Dissection During Radical Cystectomy: Where and Why!
Herr HW
2010 - January
Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles
Birkhahn M, Mitra AP, Williams AJ et al
with the following accompanying Editorial and reply from the Authors
In Search of the Perfect Crystal Ball for Ta Urothelial Cancer
Chin JL
Reply from Authors re: Joseph L. Chin. In Search of the Perfect Crystal Ball for Ta Urothelial Cancer. Eur Urol 2010;57:21–2
Mitra AP, Birkhahn M, Cote RJ
Bacillus Calmette-Guérin Is Superior to a Combination of Epirubicin and Interferon-?2b in the Intravesical Treatment of Patients with Stage T1 Urinary Bladder Cancer. A Prospective, Randomized, Nordic Study
Duchek M, Johansson R, Jahnson S et al
with the following accompanying Editorial
What is the Optimal Treatment Strategy for T1 Bladder Tumors?
